Pulse Brain · Growing Health Evidence Index
Peer-reviewed

External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial

David P. Taggart, Yulia Gavrilov, George Krasopoulos, Cha Rajakaruna, Joseph Zacharias, Ravi De Silva, Keith M. Channon, Thomas Gehrig, Terrence J. Donovan, Ivar Friedrich, Umberto Benedetto, Hunaid A. Vohra, Mohamad N Bittar, Amal Bose, Marius Berman, Rajesh Kharbanda, Alexandros Paraforos, Leonid Ladyshenskij, Nikolaos Bonaros, Thomas Schachner, Sigrid Sandner, Philipp Angleitner, Gil Bolotin, Stephan Jacobs, Matthias Thielmann, Daniel Wendt, Yeong‐Hoon Choi, Oliver J. Liakopoulos, Sunil K. Ohri, Alexander Lipey

Journal of Thoracic and Cardiovascular Surgery · 2021

Read source ↗ All evidence

Summary

OBJECTIVES: Little data exist regarding the potential of external stents to mitigate long-term disease progression in saphenous vein grafts. We investigated the effect of external stents on the progression of saphenous vein graft disease. METHODS: A total of 184 patients undergoing isolated coronary artery bypass grafting, using an internal thoracic artery graft and at least 2 additional saphenous vein grafts, were enrolled in 14 European centers. One saphenous vein graft was randomized to an external stent, and 1 nonstented saphenous vein graft served as the control. The primary end point was the saphenous vein graft Fitzgibbon patency scale assessed by angiography, and the secondary end point was saphenous vein graft intimal hyperplasia assessed by intravascular ultrasound in a prespecif

Source type
Peer-reviewed study
DOI
10.1016/j.jtcvs.2021.03.120
Catalogue ID
SNmojmgkty-iuc87h
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.